Alterations in DNA methylation resulting from IDH mutations are common in a wide range of cancers, including but not limited to acute myeloid leukemia, glioma, and cholangiocarcinoma (Figure 3) (36–39). Here, IDH2 is linked to acute myeloid leukemia.